Oct 29, 2020 / 12:00PM GMT
Operator
Good morning, my name is Julianne, and I will be your conference operator today. At this time, I would like to welcome everyone to the Lexicon Pharmaceuticals' Third Quarter 2020 Financial Results Call. (Operator Instructions)
I would now like to hand the conference over to your first speaker today, Chas Schultz. You may begin.
Chas Schultz - Lexicon Pharmaceuticals, Inc. - Executive Director of Corporate Communications & Patient Advocacy
Thank you, Julianne. Good morning, and welcome to the Lexicon Pharmaceuticals Third Quarter 2020 Financial Results and Clinical Update Conference Call. Joining me today are Lonnel Coats, Lexicon's President and Chief Executive Officer; Dr. Praveen Tyle, Lexicon's Executive Vice President of Research and Development; and Jeff Wade, Lexicon's Executive Vice President of Corporate and Administrative Affairs and Chief Financial Officer.
Earlier today, Lexicon issued a press release announcing our financial results for the third quarter of 2020, which is available on our website at
Q3 2020 Lexicon Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers